Additionally, immunohistochemical analysis of PIEZO1 in 183 patients with gliomas suggested that PIEZO1, as an independent factor, has an adverse impact on the prognosis of glioma patients [90]. This evidence concerns the gene PIEZO1 and central nervous system cancer.